ангиотензин转化酶2是一种用于向光动力学SARS-CoV-2无活化的分子诱
Andrea Mussini1, Matteo Mariangeli2, Pietro Delcanale1
1Dipartimento di Scienze Matematiche, Fisiche e Informatiche, Università di Parma, Italy.
International journal of biological macromolecules
|July 19, 2025
概括
研究人员开发了一种新的超分子结构,使用 ангиотензин转化酶2 (ACE2) 作为诱来提供光活性化合物,通过光动力疗法和结合抑制有效地使SARS-CoV-2无活化.
科学领域:
- 生物化学 生化学
- 病毒学 病毒学
- 纳米技术 纳米技术
背景情况:
- ангиотензин转化酶2 (ACE2) 对于SARS-CoV-2进入宿主细胞至关重要.
- 病毒的Spike蛋白与ACE2具有很高的亲和力.
- 开发阻止病毒进入的策略对于对抗SARS-CoV-2至关重要.
研究的目的:
- 用ACE2作为分子诱来设计一个超分子结构.
- 为了将光活性分子输送到SARS-CoV-2表面进行无活化.
- 为了研究这种结构在减少病毒载量的有效性.
主要方法:
- 使用模块化方法创建了一个自组装的,光活性超分子结构.
- 生物化复合溶性人类ACE2 (rshACE2) 被用作分子诱.
- 使用光剂或光敏剂功能化的斯特雷普塔维丁与rshACE2.2结合.
- 使用了先进的显微镜技术 (STED,dSTORM) 和光相关谱 (FCS).
主要成果:
- 超分子结构证明与SARS-CoV-2病毒颗粒结合.
- 一个光敏化单元的存在使得病毒的光不活化.
- 在暴露于光线后,病毒标位降低了1000倍以上.
- 在黑暗中通过抑制病毒与宿主细胞受体结合,也观察到显著的病毒失活 (>1000倍减少).
结论:
- 开发的基于ACE2的超分子结构有效地为SARS-CoV-2提供光活性剂.
- 这种方法为病毒无活化提供了双重机制:光动力疗法和阻断宿主细胞进入.
- 这项研究为开发针对SARS-CoV-2的新型抗病毒疗法提出了一个有前途的战略.
相关概念视频
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
891
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
891
Antihypertensive Drugs: Direct Renin Inhibitors
830
The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
830
Antihypertensive Drugs: Angiotensin II Receptor Blockers
928
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
928
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
511
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
511


